BioCentury
ARTICLE | Company News

Affymetrix, Millennium, Bristol-Myers other research news

September 17, 2001 7:00 AM UTC

Researchers published in the Proceedings of the National Academy of Sciences that gene transcription profiling of 60 cancer cell lines allowed determination of resistance or sensitivity to 88 out of 2...